In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist five patents from the Food and Drug Administration (FDA)’s ...
PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new ...
Teva Respiratory, an affiliate of Teva Pharmaceutical Industries, completed its digital inhaler portfolio today with the launch of two new products: the AirDuo Digihaler and the ArmonAir Digihaler.
When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and ...
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed. Gecko's ...
With the backing of the U.S. Federal Trade Commission, Amneal convinced a New Jersey federal court on Monday to remove five Teva Pharmaceutical patents from a Food and Drug Administration list of ...
Last week, the FTC issued a civil investigative demand, effectively a subpoena, to Teva. This demand compels the company to provide internal communications, analysis, and financial data related to the ...
Both products deliver dry powder asthma medication through Teva’s RespiClick inhaler. The AirDuo RespiClick contains the same active ingredients as GlaxoSmithKline’s inhaler drug Advair, while the ...
The FTC has begun an investigation of Teva Pharmaceutical (NYSE:TEVA) over its apparent refusal to withdraw patents related to its asthma and COPD inhalers that the agency argues is delaying generic ...
Press releases are posted on Independent.com as a free community service. PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, Inc., a U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results